Bionano Genomics, Inc. (BNGO) Total liabilities 2017–2025
Bionano Genomics, Inc. (BNGO) total liabilities at each fiscal year-end, per SEC filings.
$29.2MFY2025 · since FY2017: $17.4M → $29.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $29.2M | -29.4% |
| FY2024 | $41.3M | -65.1% |
| FY2023 | $118.2M | +103.5% |
| FY2022 | $58.1M | +45.3% |
| FY2021 | $40.0M | +57.6% |
| FY2020 | $25.4M | -4.6% |
| FY2019 | $26.6M | +81.3% |
| FY2018 | $14.7M | -15.5% |
| FY2017 | $17.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice